APA (7th ed.) Citation

T, B., N, F., L, S., TR, O., CT, M., CJ, S., . . . S, L. (2022). Pathologic responses in oligometastatic NSCLC patients treated with neoadjuvant immune checkpoint blockade with and without chemotherapy followed by surgery. Lung cancer (Amsterdam, Netherlands), 164, 46. https://doi.org/10.1016/j.lungcan.2021.11.009

Chicago Style (17th ed.) Citation

T, Boch, et al. "Pathologic Responses in Oligometastatic NSCLC Patients Treated with Neoadjuvant Immune Checkpoint Blockade with and Without Chemotherapy Followed by Surgery." Lung Cancer (Amsterdam, Netherlands) 164 (2022): 46. https://doi.org/10.1016/j.lungcan.2021.11.009.

MLA (9th ed.) Citation

T, Boch, et al. "Pathologic Responses in Oligometastatic NSCLC Patients Treated with Neoadjuvant Immune Checkpoint Blockade with and Without Chemotherapy Followed by Surgery." Lung Cancer (Amsterdam, Netherlands), vol. 164, 2022, p. 46, https://doi.org/10.1016/j.lungcan.2021.11.009.